東(dong)瑞(rui)制藥始創于1995年12月,主(zhu)要從事(shi)頭(tou)孢類抗生素以及系統專科藥物的(de)開發(fa)、制造及銷售。東(dong)瑞(rui)制藥(控股)有限公司(si)于2003年7月11日在香港(gang)聯交所(suo)主(zhu)板上市(shi),股份代(dai)號(hao):2348。
東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)製藥(控股)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)下轄東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)國(guo)際有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)國(guo)際股份有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)生(sheng)物投資(zi)發展(亞(ya)洲)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、蘇州(zhou)東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)製藥有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、蘇州(zhou)東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)醫(yi)藥科技有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)(南通)醫(yi)藥科技有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)藥業(ye)(香(xiang)港)有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)、福(fu)建東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)制(zhi)藥有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)及蘭州(zhou)東(dong)(dong)(dong)瑞(rui)(rui)(rui)(rui)制(zhi)藥有(you)限(xian)公(gong)(gong)(gong)(gong)司(si)(si)等九家子公(gong)(gong)(gong)(gong)司(si)(si)。作(zuo)為香(xiang)港上市公(gong)(gong)(gong)(gong)司(si)(si),本集團整體決策(ce)管(guan)理嚴(yan)格恪守(shou)香(xiang)港企業(ye)管(guan)治要求(qiu),業(ye)務定位面向全球(qiu),具(ju)備全球(qiu)視角和世界文化包容性,是投資(zi)者可信(xin)賴的企業(ye)。
東瑞制(zhi)藥(yao)(yao)頭孢(bao)類抗(kang)(kang)生(sheng)素產(chan)品(pin)(pin)包括中間(jian)體、原(yuan)料(liao)藥(yao)(yao)和(he)粉針劑(ji);專科藥(yao)(yao)物(wu)覆蓋心血管(guan)系(xi)(xi)統(tong)、抗(kang)(kang)乙肝病毒、抗(kang)(kang)過敏、消化系(xi)(xi)統(tong)、泌尿系(xi)(xi)統(tong)和(he)內分泌系(xi)(xi)統(tong),劑(ji)型(xing)有(you)片劑(ji)、膠囊劑(ji)、顆(ke)粒劑(ji)。在頭孢(bao)類抗(kang)(kang)生(sheng)素生(sheng)產(chan)方面,東瑞制(zhi)藥(yao)(yao)形成了(le)從藥(yao)(yao)物(wu)中間(jian)體、原(yuan)料(liao)藥(yao)(yao)到制(zhi)劑(ji)的綜合(he)性(xing)生(sheng)產(chan)特色(se),尤(you)其在第三代(dai)頭孢(bao)菌素合(he)成方面擁有(you)先進技術平臺(tai),產(chan)品(pin)(pin)質量達到國際(ji)先進水(shui)平,構(gou)建了(le)品(pin)(pin)種系(xi)(xi)列(lie)齊(qi)全(quan)、綜合(he)配套功(gong)能完善、產(chan)能潛力大(da)的頭孢(bao)產(chan)業鏈,是國內各大(da)型(xing)藥(yao)(yao)品(pin)(pin)廠(chang)商和(he)眾多國外藥(yao)(yao)品(pin)(pin)廠(chang)商的原(yuan)料(liao)供應商。
東(dong)瑞(rui)(rui)制(zhi)藥(yao)研(yan)發中(zhong)心(xin)成(cheng)立于2002年(nian),核心(xin)研(yan)發人(ren)員近50人(ren),是一支以(yi)專業技術人(ren)員為骨(gu)干,由(you)博士、碩(shuo)士等研(yan)究人(ren)員組成(cheng)的(de)研(yan)發團(tuan)隊。研(yan)發方向(xiang)主(zhu)要(yao)以(yi)系(xi)統專科藥(yao)物(wu)仿制(zhi)藥(yao)為主(zhu),同時兼顧三(san)類(lei)新(xin)藥(yao)的(de)研(yan)發和一些(xie)創新(xin)藥(yao)的(de)探索,每(mei)年(nian)研(yan)發投入約(yue)占系(xi)統專科藥(yao)物(wu)銷售金額的(de)10%。目前(qian),東(dong)瑞(rui)(rui)制(zhi)藥(yao)已建立起“安”系(xi)列心(xin)血(xue)管(guan)藥(yao)物(wu)品牌,而本集團(tuan)的(de)專科藥(yao)物(wu)苯磺酸氨氯(lv)地平片(安內真®)、氯(lv)沙(sha)坦鉀(jia)氫氯(lv)噻(sai)嗪(qin)片(安內喜®)、鹽酸西替利嗪(qin)片(西可(ke)韋(wei)®)、恩替卡(ka)韋(wei)分散片(雷易(yi)得®)皆為國內獲(huo)準生產(chan)上(shang)市的(de)產(chan)品,市場占有率位居前(qian)列。
東瑞(rui)制藥(yao)按(an)不同的產品(pin)線組建4支銷售隊伍,分別涵蓋醫院(yuan)、流通、原料及進出口幾種模式(shi)。現有(you)銷售人員550人左右(you),在全國(guo)擁有(you)90多個(ge)辦事處,其(qi)中40%在一線城(cheng)市,30%在二(er)線城(cheng)市,因此東瑞(rui)制藥(yao)具(ju)備(bei)將(jiang)新(xin)產品(pin)迅(xun)速覆蓋到醫院(yuan)的良好能力。
東(dong)瑞制藥(yao)擁(yong)有完善的(de)質量管理體系,現有廠房嚴(yan)格按照(zhao)歐(ou)盟標準建設(she)。東(dong)瑞制藥(yao)將始終以致(zhi)力于人類的(de)健(jian)康(kang)事(shi)業(ye)為(wei)己(ji)任,憑借高度的(de)社(she)會責任感與前瞻性(xing)的(de)思維(wei),通(tong)過(guo)持續的(de)技術創新(xin),不斷為(wei)社(she)會提(ti)供(gong)安全有效的(de)藥(yao)物(wu),成為(wei)世(shi)界先進(jin)的(de)制藥(yao)企業(ye),為(wei)人類的(de)健(jian)康(kang)事(shi)業(ye)作極致(zhi)的(de)貢獻(xian)。